Sign In
Last checked at 
27 Jul 2020 07:00
27 July 2020
Sabien Technology Group plc
("Sabien" or the "Company")
Update re. Suspension
Following the announcement on 20 January 2020 regarding the possible acquisition of Ptarmigan Health Destinations SA, the Company's shares were suspended from trading on AIM with immediate effect. This is because the transaction would be classified as a reverse takeover in accordance with the AIM Rules for Companies ("AIM Rules"). Under the AIM Rules, the Company has six months from the date of suspension to publish an admission document setting out, inter alia, details of the proposed transaction or confirm these discussions have ceased. If neither of these outcomes is achieved, trading in the Company's shares will be cancelled.
Due to market impact of Covid-19 the Company has been granted an extension from six to twelve months from 20 January 2020 for publishing such an admission document or to confirm discussions concerning a transaction have ceased.
For further information:
Sabien Technology Group plc Richard Parris, Chairman
Allenby Capital Limited (Nominated Adviser) John Depasquale / Asha Chotai
Peterhouse Capital Limited (Broker) Duncan Vasey/ Lucy Williams
| +44 20 7993 3700
+44 203 328 5656
+44 207 469 0930 | ||
A copy of this announcement will be available from the Company's website at www.sabien-tech.co.uk
|
Follow the stocks
